FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:753-755 August 14, 2008 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Cummings, S. R. PubMed Citation

Since the mean life expectancy at menopause is 32.7 years, women spend more than one third of their lives in the estrogen-deficient postmenopausal state.¹ Of the majority of menopausal women who have climacteric symptoms, 20% describe them as intolerable, and one third have such symptoms for up to 5 years.² During her lifetime, one of every two women will have an osteoporotic fracture, one third will have coronary heart disease, one fifth will have a stroke or Alzheimer's disease, and one eighth will have breast cancer.

Whereas hormone-replacement therapy was once accepted as the ideal strategy for optimizing postmenopausal health . . . [Full Text of this Article]

Source Information

From the Calcium Metabolism and Osteoporosis Program, the American University of Beirut Medical Center, Beirut, Lebanon.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.